Article
Adrenomedullin signaling pathway polymorphisms and adverse pregnancy outcomes.
American journal of perinatology - 1 Apr 2014
Lenhart Patricia M, Nguyen Thutrang, Wise Alison, Caron Kathleen M, Herring Amy H, Stuebe Alison M
Abstract excerpt
OBJECTIVE: Reduced maternal plasma levels of the peptide vasodilator adrenomedullin have been associated with adverse pregnancy outcomes. We measured the extent to which genetic polymorphisms in the adrenomedullin signaling pathway are associated with birth weight, glycemic regulation, and preeclampsia risk. STUDY DESIGN: We genotyped 1,353 women in the Pregnancy, Infection, and Nutrition Postpartum Study for 37...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
